Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction

American Heart Journal

Volumn 159, Issue 3, 2010, Pages 354-360

  Taljaard, Monica ^a,b   Ward, Michael R ^c   Kutryk, Michael J B ^d   Courtman, David W ^d   Camack, Nancy J ^a   Goodman, Shaun G ^d   Parker, Thomas G ^d   Dick, Alexander J ^e   Galipeau, Jacques ^f   Stewart, Duncan J ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GADOLINIUM PENTETATE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; APHERESIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL POPULATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DOUBLE BLIND PROCEDURE; ENDOTHELIUM CELL; FEMALE; GENE THERAPY; GENETIC TRANSFECTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN CELL; INJECTION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION;

DOUBLE-BLIND METHOD; HUMANS; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE TYPE III; RESEARCH DESIGN; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSFECTION; TRANSPLANTATION, AUTOLOGOUS; UP-REGULATION;

EID: 77649296527     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.12.021     Document Type: Article

References (40)

1. NHLBI and NIH. Morbidity & mortality: 2007 chart book on cardiovascular, lung, and blood diseases. Available at:. http://www.nhlbi.nih.gov/resources/docs/07-chtbk.pdf Last accessed March 2009
2. Parikh N.I., Gona P., Larson M.G., et al. Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart Study. Circulation 119 (2009) 1203-1210
3. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119 (2009) e1-e161
4. Kawamoto A., Tkebuchava T., Yamaguchi J., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107 (2003) 461-468
5. Fuchs S., Baffour R., Zhou Y., et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37 (2001) 1726-1732
6. Kamihata H., Matsubara H., Nishiue T., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
7. Schachinger V., Erbs S., Elsässer A., et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27 (2006) 2775-2783
8. Schachinger V., Erbs S., Elsässer A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
9. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167 (2007) 989-997
10. Lipinski M.J., Biondi-Zoccai G.G.L., Abbate A., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50 (2007) 1761-1767
11. Martin-Rendon E., Brunskill S.J., Hyde C.J., et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29 (2008) 1807-1818
12. Granger C.B., White H.D., Bates E.R., et al. A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. Am J Cardiol 74 (1994) 1220-1228
13. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98 (2001) 10344-10349
14. Kawamoto A., Gwon H., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
15. Nishida M., Li T., Hirata K., et al. Improvement of cardiac function by bone marrow cell implantation in a rat hypoperfusion heart model. Ann Thorac Surg 75 (2003) 768-773
16. Kawamoto A., Asahara T., and Losordo D.W. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med 3 (2002) 221-225
17. Ward M.R., Thompson K.A., Keith M., et al. Endothelial progenitor cells from patients with multiple coronary artery disease risk factors exhibit reduced regenerative capacity in vitro and in vivo. Circulation 114 (2006)
18. Hill J.M., Zalos G., Halcox J.P.J., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
19. Heeschen C., Lehmann R., Honold J., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109 (2004) 1615-1622
20. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
21. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
22. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
23. Knoke J.D. Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error. Biometrics 47 (1991) 523-533
24. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95 (2004) 343-353
25. Hur J., Yoon C.H., Kim H.S., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24 (2004) 288-293
26. Landmesser U., and Drexler H. The clinical significance of endothelial dysfunction. Curr Opin Cardiol 20 (2005) 547-551
27. Sherman D.L., and Loscalzo J. Endothelial dysfunction and cardiovascular disease. Cardiologia 42 (1997) 177-187
28. Aicher A., Heeschen C., Mildner-Rihm C., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9 (2003) 1370-1376
29. Guthrie S.M., Curtis L.M., Mames R.N., et al. The nitric oxide pathway modulates hemangioblast activity of adult hematopoietic stem cells. Blood 105 (2005) 1916-1922
30. Heiss C., Keymel S., Niesler U., et al. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 45 (2005) 1441-1448
31. Dzau V.J., Gnecchi M., Pachori A.S., et al. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 46 (2005) 7-18
32. Sasaki K., Heeschen C., Aicher A., et al. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci U S A 103 (2006) 14537-14541
33. Kudo F.A., Nishibe T., Nishibe M., et al. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int Angiol 22 (2003) 344-348
34. Bartunek J., Vanderheyden M., Vandekerckhove B., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112 (2005) I178-I183
35. Stamm C., Westphal B., Kleine H., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
36. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
37. Kong D., Melo L.G., Mangi A.A., et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109 (2004) 1769-1775
38. Wijelath E.S., Rahman S., Murray J., et al. Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J Vasc Surg 39 (2004) 655-660
39. Butler E.K., Desjardins J., Leong-Poi H., et al. Critical dependence on timing of cardiac injection for engraftment of endothelial progenitor cells and functional benefit post-myocardial infarction. Circulation 114 (2006) II_15
40. Assmus B., Schächinger V., Erbs S., et al. Acute myocardial infarction activates progenitor cells in the bone marrow of patients with coronary artery disease. Circulation 114 (2006) II_739